FDA Approval Makes Deciphera’s Qinlock First Fourth-Line GIST Drug

 
• By Mandy Jackson
  
3d render illustration of human digestive system - front view
Qinlock is the first fourth-line GIST drug approved in the US
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip